429 related articles for article (PubMed ID: 18705442)
1. Demography, clinical and laboratory features of systemic sclerosis in a Malaysian rheumatology centre.
Pagalavan L; Ong SG
Med J Malaysia; 2007 Jun; 62(2):117-21. PubMed ID: 18705442
[TBL] [Abstract][Full Text] [Related]
2. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
3. Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients.
Poormoghim H; Lucas M; Fertig N; Medsger TA
Arthritis Rheum; 2000 Feb; 43(2):444-51. PubMed ID: 10693887
[TBL] [Abstract][Full Text] [Related]
4. Juvenile systemic sclerosis: a follow-up study of eight patients.
Szamosi S; Maródi L; Czirják L; Ellenes Z; Szücs G
Ann N Y Acad Sci; 2005 Jun; 1051():229-34. PubMed ID: 16126963
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous and serologic subsets of systemic sclerosis.
Ferri C; Bernini L; Cecchetti R; Latorraca A; Marotta G; Pasero G; Neri R; Bombardieri S
J Rheumatol; 1991 Dec; 18(12):1826-32. PubMed ID: 1795320
[TBL] [Abstract][Full Text] [Related]
6. [Anti-Scl-70 antibodies in systemic scleroderma].
Le Thi Huong ; Sauvaget F; Johanet C; De Gennes C; Raguin G; Abuaf N; Blétry O; Guillevin L; Homberg JC; Godeau P
Ann Dermatol Venereol; 1990; 117(2):103-7. PubMed ID: 2111650
[TBL] [Abstract][Full Text] [Related]
7. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis.
Cutolo M; Pizzorni C; Tuccio M; Burroni A; Craviotto C; Basso M; Seriolo B; Sulli A
Rheumatology (Oxford); 2004 Jun; 43(6):719-26. PubMed ID: 15026581
[TBL] [Abstract][Full Text] [Related]
8. [Antiendothelial antibodies in systemic scleroderma and Raynaud's disease].
Salozhin KV; Shcherbakov AB; Nasonov EL; Kolesova NV; Romanov IuA; Guseva NG
Ter Arkh; 1995; 67(5):54-7. PubMed ID: 7638782
[TBL] [Abstract][Full Text] [Related]
9. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry.
Khimdas S; Harding S; Bonner A; Zummer B; Baron M; Pope J;
Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608
[TBL] [Abstract][Full Text] [Related]
10. A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies.
Cavazzana I; Fredi M; Taraborelli M; Quinzanini M; Tincani A; Franceschini F
Clin Exp Rheumatol; 2013; 31(2 Suppl 76):118-21. PubMed ID: 23910615
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
Koenig M; Joyal F; Fritzler MJ; Roussin A; Abrahamowicz M; Boire G; Goulet JR; Rich E; Grodzicky T; Raymond Y; Senécal JL
Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499
[TBL] [Abstract][Full Text] [Related]
12. Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database.
Martini G; Foeldvari I; Russo R; Cuttica R; Eberhard A; Ravelli A; Lehman TJ; de Oliveira SK; Susic G; Lyskina G; Nemcova D; Sundel R; Falcini F; Girschick H; Lotito AP; Buoncompagni A; Sztajnbok F; Al-Mayouf SM; Orbàn I; Ferri C; Athreya BH; Woo P; Zulian F;
Arthritis Rheum; 2006 Dec; 54(12):3971-8. PubMed ID: 17133611
[TBL] [Abstract][Full Text] [Related]
13. A study of the prevalence of systemic sclerosis in northeast England.
Allcock RJ; Forrest I; Corris PA; Crook PR; Griffiths ID
Rheumatology (Oxford); 2004 May; 43(5):596-602. PubMed ID: 14872101
[TBL] [Abstract][Full Text] [Related]
14. Antiendothelial cell antibodies in scleroderma correlate with severe digital ischemia and pulmonary arterial hypertension.
Negi VS; Tripathy NK; Misra R; Nityanand S
J Rheumatol; 1998 Mar; 25(3):462-6. PubMed ID: 9517764
[TBL] [Abstract][Full Text] [Related]
15. Anti-PM/Scl autoantibodies in patients without clinical polymyositis or scleroderma.
Schnitz W; Taylor-Albert E; Targoff IN; Reichlin M; Scofield RH
J Rheumatol; 1996 Oct; 23(10):1729-33. PubMed ID: 8895149
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to fibrin bound tissue type plasminogen activator in systemic sclerosis.
Fritzler MJ; Hart DA; Wilson D; García-De La Torre I; Salazar-Páramo M; Vázquez-Del Mercado M; Senécal JL; Loyau S; Anglés-Cano E
J Rheumatol; 1995 Sep; 22(9):1688-93. PubMed ID: 8523346
[TBL] [Abstract][Full Text] [Related]
17. [Clinical study on two cases of progressive systemic sclerosis with anti Wa antibody].
Mita S; Adachi M; Tomii M; Matsuoka Y; Irimajiri S; Miyachi K; Takano S; Matsushima H; Hiwatashi T
Ryumachi; 1989 Oct; 29(5):365-70. PubMed ID: 2634885
[TBL] [Abstract][Full Text] [Related]
18. Juvenile systemic sclerosis: report of three cases and review of Japanese published work.
Aoyama K; Nagai Y; Endo Y; Ishikawa O
J Dermatol; 2007 Sep; 34(9):658-61. PubMed ID: 17727371
[TBL] [Abstract][Full Text] [Related]
19. [Clinical features of systemic sclerosis and association with antitopoisomerase-1 antibody and centromere pattern of antinuclear antibody].
Bertazzi GR; de Toledo RA; de Godoy MF; Geraldino GC; Polizelli DV; Fernandes GC; Pedroso CL; dos Santos FG; de Assis TM
Acta Reumatol Port; 2012; 37(1):9-17. PubMed ID: 22781510
[TBL] [Abstract][Full Text] [Related]
20. Clinical burden of digital vasculopathy in limited and diffuse cutaneous systemic sclerosis.
Nihtyanova SI; Brough GM; Black CM; Denton CP
Ann Rheum Dis; 2008 Jan; 67(1):120-3. PubMed ID: 17660220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]